Summary of the proceedings of the United States-Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998

Lung Cancer

Volumn 24, Issue 3, 1999, Pages 181-191

  Leigh, Bryan R ^a   Gandara, David R ^a   Crowley, John J ^b   Furuse, Kiyoyuki ^c   Livingston, Robert B ^d   Fukushima, Masanori ^e   Coltman Jr , Charles A ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b USA   (United States)

^c Hlth Ins Union Osaka Ctrl H   (Japan)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f Southwest Oncology Group   (United States)

Author keywords

Chemotherapy; Clinical trials; Non small cell lung cancer; Radiotherapy; Small cell lung cancer; Surgery

Indexed keywords

ANTIINFECTIVE AGENT; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; ISONIAZID; MITOMYCIN; NAVELBINE; PACLITAXEL; TEGAFUR; TIRAPAZAMINE; URACIL;

ADJUVANT CHEMOTHERAPY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; JAPAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; UNITED STATES;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CLINICAL TRIALS; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; UNITED STATES;

EID: 0033051949     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(99)00037-9     Document Type: Conference Paper

References (25)

1. Albain K.S., Rusch V.W., Crowley J.J., Rice T.W., Turrisi A.T., Weick J.K., Lonchyna V.A., Presant C.A., McKenna R.J., Gandara D.R., Fosmire H., Taylor S.A., Stelzer K.J., Beasley K.R., Livingston R.B. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol. 13:1995;1880-1892.
2. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., Hartman A.M., Palmgren J., Freedman L.S., Haapakoski J., Barrett M.J., Pietinen P., Malila N., Tala E., Liippo K., Salomaa E.R., Tangrea J.A., Teppo L., Askin F.B., Taskinen E., Erozan Y. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Nat Cancer Inst. 88:1996;1560-1570.
3. Dillman R.O., Seagren S.L., Propert K.J., Guerra J., Eaton W.L., Perry M.C., Carey R.W., Frei E.F., Green M.R. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. New Engl J Med. 323:1990;940-945.
4. Eberhardt W., Wilke H., Stamatis G., Stuschke M., Harstrick A., Mueller M.R., Kolks S., Stahl M., Klassen U., Flasshove M., Greschuchna D., Konietzko N., Seeber S. Preliminary results of a stage orientated multimodality treatment including surgery for selected subgroups of limited disease small cell lung cancer. Lung Cancer. 18:1997;235.
5. Ebi N., Kubota K., Nishiwaki Y., Hojo F., Matsumoto T., Kakinuma R., Ohmatsu H., Sekine I., Yokozaki M., Gotoh K., Yamamoto H., Kodama T. Second-line chemotherapy for relapsed small cell lung cancer. Jpn J Clin Oncol. 27:1997;166-169.
6. Furuse K., Fukuoka M., Takada Y., Nishikawa H., Katagami N., Ariyosahi Y. A randomized phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer: preliminary analysis. Proceedings of ASCO. 16:1997;1649.
7. Harpole D.H., Liptay M.J., DeCamp M.M., Mentzer S.J., Swanson S.J., Sugarbaker D.J. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 61:1996;977-982.
8. Kubota K., Nishiwaki Y., Kakinuma R., Hojo F., Matsumoto T., Ohmatsu H., Sekine I., Yokozaki M., Gotoh K., Ebi N., Kodama T. Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer. J Clin Oncol. 15:1997;292-296.
9. Lau D.H., Crowley J.J., Gandara D.R., Hazuka M.B., Albain K.S., Leigh B.R., Fletcher W.S., Lanier K.S., Keiser L.W., Livingston R.B. A Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide and radiation for poor-risk stage III non-small cell lung cancer. J Clin Oncol. 16:1998;3078-3081.
10. Livingston R.B., Tsuchiya R., Fukushima M., Coltman C.A. Jr Summary of the proceedings of the United States-Japan lung cancer clinical trials summit. Hawaii, 24-25 February 1996. J Cancer Res Clin Oncol. 123:1997;461-466.
11. Martinez-Monge R., Herreros J., Aristu J.J., Aramendia J.M., Azinovic I. Combined treatment in superior sulcus tumors. Am J Clin Oncol. 17:1994;317-322.
12. Mitsudomi T., Mizoue T., Yoshimatsu T., Oyama T., Nakanishi R., Okabayashi K., Osaki T., Kume T., Yasumoto K., Sugimachi K. Postoperative complications after pneumonectomy for treatment of lung cancer: multivariate analysis. J. Surg Oncol. 61:1996;218-222.
13. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J. 311:1995;899-909.
14. Omenn G.S., Goodman G., Thornquist M., Barnhart S., Balmes J., Cherniack M., Cullen M., Glass A., Keogh J., Liu D., Meyskens F., Perloff M., Valanis B. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. Iarc Sci Publ. 136:1996;67-85.
15. Pignon J.P., Arriagada R., Ihde D.C., Johnson D.H., Perry M.C., Souhami R.L., Brodin O., Joss R.A., Kies M.S., Lebeau B. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. New Engl J Med. 327:1992;1618-1624.
16. Rothenberg M.L., Coltman C.A. Jr, Fukushima M. Summary of a joint meeting between the Southwest Oncology Group and the Japanese Clinical Trials Consortium. J Cancer Res Clin Oncol. 119:1993;564-567.
17. Rothenberg M.L., Fukushima M., Coltman Jr C.A. Gastric and esophageal cancers: Perspectives from a U.S.-Japan meeting. J Cancer Res Clin Oncol. 120:1994;747-753.
18. Sandler A., Nemunaitis J., Dehnam C., Cormier Y., von Pawel J., Niyikiza C., Nguyen D., Einhorn L. Phase III study of cisplatin with or without gemcitabine in patients with advanced nonsmall cell lung cancer. Proceedings of ASCO. 17:1998;1747.
19. Sause W.T., Scott C., Taylor S., Johnson D., Livingston R., Komaki R., Emami B., Curran W.J., Byhardt R.W., Turrisi A.T., Dar A.R., Cox J.D. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Nat Cancer Inst. 87:1995;198-205.
20. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). Eur J Surg Oncol. 21:1995;69-77.
21. Turrisi A.T., Kim K., Blum R., Sause W.T., Livingston R., Komaki R., Wagner H., Aisner S., Johnson D.H. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. New Engl J Med. 340:1999;265-271.
22. Uchida A., Fukushima M., Rothenberg M.L., Coltman C.A. Jr Bone and soft tissue sarcomas: summary of the Third United States/Japan Clinical Trials Summit (Seattle, Washington). J Cancer Res Clin Oncol. 123:1997;674-677.
23. von Pawel J., von Roemeling R. Survival benefit from tirazone (tirapazamine) and cisplatin in advanced non-small cell lung cancer patients: final results from the international phase III catapult I trial. Proceedings of ASCO. 17:1998;1749.
24. Wada H., Hitomi S., Teramatsu T. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. J Clin Oncol. 14:1996;1048-1054.
25. Wozniak A.J., Crowley J.J., Balcerzak S.P., Weiss G.R., Spiridonidis C.H., Baker L.H., Albain K.S., Kelly K., Taylor S.A., Gandara D.R., Livingston R.B. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol. 16:1998;2459-2465.